Picture of Arcoma AB logo

ARCOMA Arcoma AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for Arcoma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.793.134.6613.76.24
Depreciation
Non-Cash Items0.088-1.070.109-0.6091.52
Other Non-Cash Items
Changes in Working Capital0.65-8.836.3-2.143.63
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.93-0.17919.218.818.7
Capital Expenditures-4.19-4.17-2.55-6.78-5.62
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-4.19-4.17-2.55-6.78-5.62
Financing Cash Flow Items-3.058.35-18.300
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.49.65-21.2-3.8710.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3.754.83-4.668.3821.9